Applied DNA Urges Shareholders to Vote Ahead of February 14 Meeting

Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, has reminded its shareholders of the need to vote before the company's reconvened Special Meeting on February 14, 2025. Originally set for January 23, 2025, the meeting was postponed due to a lack of quorum, extending the voting period on the Warrant Exercise Proposal.

The Board of Directors urges shareholders, particularly those registered as of November 25, 2024, to vote through Kingsdale Advisors. Stockholders will decide on the proposal related to the exercisability of certain stock warrants issued on October 30, 2024, in line with Nasdaq Rule 5635(d).

The definitive proxy statement is available to shareholders and crucial for informed voting. Applied DNA emphasizes that all relevant documents are vital for shareholders' decisions.